MetroPlus Health Plan Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • MetroPlus Health Plan's estimated annual revenue is currently $1B per year.(i)
  • MetroPlus Health Plan's estimated revenue per employee is $378,000

Employee Data

  • MetroPlus Health Plan has 2771 Employees.(i)
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$6.7M3111%N/AN/A
#2
$9.7M4510%N/AN/A
#3
$18.2M7514%N/AN/A
#4
$78.4M26416%N/AN/A
#5
$7.3M34-3%N/AN/A
#6
$28.9M10720%N/AN/A
#7
$64.7M2186%N/AN/A
#8
$37.5M139-2%N/AN/A
#9
$6.7M31-11%N/AN/A
#10
$8M3737%N/AN/A
Add Company

MetroPlus recognizes that it is critical for members, prospects and providers to be confident that their privacy is protected when they visit MetroPlus\' website.This policy describes MetroPlus\' privacy practices regarding information collected from users of this website. This policy descri bes what information is collected and how that information is used. Because this privacy policy only applies to this website, you should examine the privacy policy of any website, including other state agency websites, that you access using this website.

keywords:N/A

N/A

Total Funding

2771

Number of Employees

$1B

Revenue (est)

N/A

Employee Growth %

N/A

Valuation

N/A

Accelerator

MetroPlus Health Plan News

2022-04-17 - Health System Designated “LGBTQ+ Healthcare Equality ...

... nursing homes, post-acute care centers, home care agency, and MetroPlus health plan—all supported by 11 essential hospitals.

2022-04-17 - Test & Trace and New York Mets Celebrate Citi Field ...

... nursing homes, post-acute care centers, home care agency, and MetroPlus health plan—all supported by 11 essential hospitals.

2022-03-22 - 2 Years Later: Health System Reflects on its Role During ...

... nursing homes, post-acute care centers, home care agency, and MetroPlus health plan—all supported by 11 essential hospitals.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1047.4M27710%N/A
#2
$1050.8M278012%N/A
#3
$300M27888%N/A
#4
$551M281114%N/A
#5
$525.4M282618%$570M